CLA-2-338:S:N:N1:238 856113
Mr. Jeremy R. Page
Katten Muchin & Zavis
525 West Monroe Street
Chicago, Illinois 60606-3693
RE: The tariff classification of three blood fraction products:
Gammagard (IGIV),Immune Globulin Intravenous (human) from
Belgium; ATnativ, Antithrombin III (human) from Sweden; and
Albumin (human) 5% and 25% solution from Switzerland.
Dear Mr.Page:
In your letter dated September 7, 1990 you requested a
tariff classification ruling on behalf of your client, Baxter
Healthcare Corporation.
The Gammagard and ATnativ consist of dried sterile
preparations isolated from human blood plasma. They will be
reconstituted for use in an intravenous solution subsequent to
importation. Albumin which is also isolated from human plasma
is prepared as 5% and 25% sterile aqueous solutions. It will
also be used for intravenous administration.
The applicable subheading for the IGIV, ATnativ, and albumin
will be 3002.10.0050, Harmonized Tariff Schedule of the United
States (HTS), which provides for antisera and other blood
fractions prepared for therapeutic, prophylactic or diagnostic
uses. The rate of duty will be free.
This merchandise may be subject to the regulations of the
Food and Drug Administration. You may contact them at 5600
Fishers Lane, Rockville, Maryland 20857, telephone number (202)
443-3380.
This ruling is being issued under the provisions of Section
177 of the Customs Regulations (19 C.F.R. 177).
A copy of this ruling letter should be attached to the entry
documents filed at the time this merchandise is imported. If the
documents have been filed without a copy, this ruling should be
brought to the attention of the Customs officer handling the
transaction.
Sincerely,
Jean F. Maguire
Area Director
New York Seaport